OmniSpirant Limited was founded by Gerry McCauley in 2016. Gerry qualified as a Master of Pharmacy in 2001. Gerry has extensive commercial knowledge, industry contacts and has built an international network of experts in the fields of cell and gene therapy and respiratory drug delivery. Gerry is the inventor of OmniSpirant’s patent pending inhaled exosome technology.
Since the company was founded a team of experienced industry leaders have joined the company’s management team. Our growing R&D team are at the forefront of innovation in the nascent field of exosome and extracellular vesicle research.